Zhilong Ai

785 total citations
36 papers, 600 citations indexed

About

Zhilong Ai is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Zhilong Ai has authored 36 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Immunology. Recurrent topics in Zhilong Ai's work include Cancer Cells and Metastasis (5 papers), Thyroid Cancer Diagnosis and Treatment (5 papers) and Cancer-related molecular mechanisms research (4 papers). Zhilong Ai is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Thyroid Cancer Diagnosis and Treatment (5 papers) and Cancer-related molecular mechanisms research (4 papers). Zhilong Ai collaborates with scholars based in China, United States and France. Zhilong Ai's co-authors include Cong Wang, Zhenglin Wang, Yinan Li, Jianhai Jiang, Yuanyan Wei, Wei Liu, Yang Xing, Xinbiao Lü, Jiaojiao Zheng and Xiaoning Chen and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Biochemical and Biophysical Research Communications.

In The Last Decade

Zhilong Ai

33 papers receiving 593 citations

Peers

Zhilong Ai
Comparison fields: 5 of 77
  • Molecular Biology 280
  • Oncology 150
  • Cancer Research 125
  • Endocrinology, Diabetes and Metabolism 96
  • Immunology 88
Replace Yimao Liu with:
Yimao Liu China
Chenyang Ye China
Chongwen Xu China
Nicolas Dif France
Yoon Yang Jung South Korea
Izo Kimijima Japan
Haiping Pei China
R Mukherjee United Kingdom
Lisa J. Weinstein United States
Yimao Liu China View profile →
Citations per field, relative to Zhilong Ai
Zhilong Ai · 1×
Citations per year, relative to Zhilong Ai
Zhilong Ai · 1×

Countries citing papers authored by Zhilong Ai

Since Specialization
Citations

This map shows the geographic impact of Zhilong Ai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhilong Ai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhilong Ai more than expected).

Fields of papers citing papers by Zhilong Ai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhilong Ai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhilong Ai. The network helps show where Zhilong Ai may publish in the future.

Co-authorship network of co-authors of Zhilong Ai

This figure shows the co-authorship network connecting the top 25 collaborators of Zhilong Ai. A scholar is included among the top collaborators of Zhilong Ai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhilong Ai. Zhilong Ai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 2
2 3
3 2
4 4
5 5
6 50
7 17
8 27
9 25
10 18
11 25
12 8
13 14
14 14
15 3
16 26
17 11
18 12
19 18
20 21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026